p mirabilis atcc 35659 (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
96
Structured Review
ATCC
p mirabilis atcc 35659
P Mirabilis Atcc 35659, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 129 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proteus+mirabilis+atcc+35659/Proteus+mirabilis%3B+LRA+08+01+73/pm41572876-50-10-12
Average 96 stars, based on 129 article reviews
P Mirabilis Atcc 35659, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 129 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/proteus+mirabilis+atcc+35659/Proteus+mirabilis%3B+LRA+08+01+73/pm41572876-50-10-12
Average 96 stars, based on 129 article reviews
p mirabilis atcc 35659 - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Plasmid Preparation:Article Title: Innovative Delivery System Combining CRISPR-Cas12f for Combatting Antimicrobial Resistance in Gram-Negative Bacteria. Article Snippet: Antimicrobial resistance poses a significant global challenge, demanding innovative approaches, such as the CRISPR-Cas-mediated resistance plasmid or genecuring system, to effectively combat this urgent crisis.. To enable successful curing of antimicrobial genes or plasmids through CRISPR-Cas technology, the development of an efficient broad-host-range delivery system is paramount.. In this study, we have successfully designed and constructed a novel functional gene delivery plasmid, pQmini, utilizing the backbone of a broad-host-range Inc.Q plasmid. Article Title: Genetic manipulations of nonmodel gut microbes Article Snippet: .. We have proved that suicide plasmid targeting strain‐specific 16s rRNA genes can be integrated into the targeted site of the genome of other Gram‐negative gut microbes, such as Fusobacterium gastrosuis DSM 101753, Fusobacterium nucleatum ATCC 25751, ATCC 10953, ATCC 23726, Klebsiella oxytoca DSM 29614, DSM 5175, DSM 7342, other:Article Title: Multitarget Phytocomplex: Focus on Antibacterial Profiles of Grape Pomace and Sambucus ebulus L. Lyophilisates Against Extensively Drug-Resistant (XDR) Bacteria and In Vitro Antioxidative Power Article Snippet: Article Title: Polyphenolic contents, antioxidant, and antimicrobial activities of Saccocalyx satureioides Coss. & Dur. essential oil and methanol extracts. Article Snippet: Reference bacterial strains were subjected to the effect of the extracts and the EO: Bacillus subtilis ATCC6633, Escherichia coli ATCC8739, Staphylococcus aureus ATCC6538, Pseudomonas aeruginosa ATCC9027, Article Title: Cosmopolitan but still untapped: Antimicrobial, antibiofilm and in silico molecular docking study on Caulerpa racemosa, Dictyopteris polypodioides and Padina pavonica Article Snippet: Other strains were obtained from the American Type Culture Collection (ATCC) included Activity Assay:Article Title: Mechanism of Antimicrobial Activities of Medicinal Plants Extracts, From Traditional Knowledge to Scientific Insights Article Snippet: .. However, some interesting studies show that carotenoids show significant antibacterial activity; Guiera plant gall (Guiera senegalensis) from Burkina Faso is rich in carotenoids and has antimicrobial activity against Staphylococus aureus ATCC 6538, Bacillus cereus 13061, Escherichia coli ATCC 25922, Salmonella typhimurium ATCC 13311, and no effect with Article Title: A Gram-negative-selective antibiotic that spares the gut microbiome. Article Snippet: Infections caused by Gram-negative pathogens are increasingly prevalent and are typically treated with broad-spectrum antibiotics, resulting in disruption of the gut microbiome and susceptibility to secondary infections.. There is a critical need for antibiotics that are selective both for Gram-negative bacteria over Gram-positive bacteria, as well as for pathogenic bacteria over commensal bacteria.. Here we report the design and discovery of lolamicin, a Gram-negative-specific antibiotic targeting the lipoprotein transport system. Control:Article Title: Anti-microbial, Anti-inflammatory and Anti-cancer Potentials of Eobaniavermiculata (Müller, 1774) Mucin-conjugated Gold Nanoparticles Article Snippet: *Corresponding Author: Heba Dahroug Microbiology Department, Theodor Bilharz Research Institute, Giza, Egypt Tel.. : 01223722782 hubbymicro@yahoo.com Background: Terrestrial snails produce slime with antimicrobial properties used in skincare products.. Mucin, derived from snail mucus, has biomedical applications like wound healing and anti-cancer purposes. Generated:Article Title: A Gram-negative-selective antibiotic that spares the gut microbiome. Article Snippet: Infections caused by Gram-negative pathogens are increasingly prevalent and are typically treated with broad-spectrum antibiotics, resulting in disruption of the gut microbiome and susceptibility to secondary infections.. There is a critical need for antibiotics that are selective both for Gram-negative bacteria over Gram-positive bacteria, as well as for pathogenic bacteria over commensal bacteria.. Here we report the design and discovery of lolamicin, a Gram-negative-specific antibiotic targeting the lipoprotein transport system. Bacteria:Article Title: A Gram-negative-selective antibiotic that spares the gut microbiome. Article Snippet: Infections caused by Gram-negative pathogens are increasingly prevalent and are typically treated with broad-spectrum antibiotics, resulting in disruption of the gut microbiome and susceptibility to secondary infections.. There is a critical need for antibiotics that are selective both for Gram-negative bacteria over Gram-positive bacteria, as well as for pathogenic bacteria over commensal bacteria.. Here we report the design and discovery of lolamicin, a Gram-negative-specific antibiotic targeting the lipoprotein transport system. Sequencing:Article Title: A Gram-negative-selective antibiotic that spares the gut microbiome. Article Snippet: Infections caused by Gram-negative pathogens are increasingly prevalent and are typically treated with broad-spectrum antibiotics, resulting in disruption of the gut microbiome and susceptibility to secondary infections.. There is a critical need for antibiotics that are selective both for Gram-negative bacteria over Gram-positive bacteria, as well as for pathogenic bacteria over commensal bacteria.. Here we report the design and discovery of lolamicin, a Gram-negative-specific antibiotic targeting the lipoprotein transport system. |